Moist Wound Dressings Market Report 2026

The moist wound dressings market size has grown strongly in recent years. It will grow from $4.91 billion in 2025 to $5.25 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to increasing prevalence of chronic wounds, rising adoption of foam and hydrocolloid dressings, growing hospital-based wound care usage, higher incidence of diabetic ulcers, early reliance on basic wound management materials.

The moist wound dressings market size is expected to see strong growth in the next few years. It will grow to $6.8 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to expansion of homecare wound treatment, development of advanced antimicrobial dressings, rising geriatric population demand, growing use of hydrogel dressings, increased investment in wound healing r&d. Major trends in the forecast period include advancement of precision regenerative wound care, rising adoption of eco-friendly sustainable dressings, growth in automated manufacturing of advanced dressings, increased use of digital platforms for wound monitoring, integration of AI-based wound assessment tools.

The rising incidence of diabetes is expected to drive the growth of the moist wound dressings market in the coming years. Diabetes is a chronic condition characterized by elevated blood sugar levels, often leading to complications such as foot ulcers and slow-healing wounds that require advanced wound care solutions. The increasing prevalence of diabetes has intensified the demand for effective wound management, as patients rely on moist wound dressings and other topical therapies to prevent infections, promote healing, and reduce the risk of severe complications. For example, in June 2024, according to the National Health Service, a UK-based government department, over half a million (549,000) additional individuals in England were identified at risk of developing type 2 diabetes in 2023, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This reflects a nearly 20% increase compared to 3,065,825 in 2022. Therefore, the rising incidence of diabetes is fueling the growth of the moist wound dressings market.

Leading companies in the moist wound dressing market are developing innovative products such as foam dressings to expand their customer base, increase sales, and boost revenue. Foam dressings are wound care products designed to manage exuding wounds effectively. For instance, in January 2023, Convatec Group PLC, a UK-based medical device company, launched ConvaFoam, a versatile wound care solution suitable for various wound types and stages, simplifying dressing selection and supporting skin protection. ConvaFoam incorporates enhanced silicone technology for superior adhesion, improved fluid handling and absorbency, an extended seven-day wear time, a patterned film for potential exudate monitoring, and a superabsorbent layer. Its adaptability is further enhanced by the ability to be custom cut, allowing application to complex and challenging wound areas.

In August 2023, Coloplast A/S, a Denmark-based manufacturer of advanced wound care products, acquired Kerecis for an undisclosed amount. This acquisition enables Coloplast to expand and strengthen its Advanced Wound Care portfolio, enhancing its position in the moist wound dressings market. Kerecis, based in Iceland, specializes in fish-skin grafts and other advanced wound care products for both chronic and acute wound management.

Major companies operating in the moist wound dressings market are 3M Company, Smith & Nephew PLC, Derma Sciences Inc., ConvaTec Group PLC, Coloplast A/S, Medline Industries Inc., Cardinal Health Inc., B. Braun Medical Inc., Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Advanced Medical Solutions Group PLC, URGO Group, Acelity L.P. Inc., Winner Medical Co. Ltd., Essity AB, AMERX Health Care Corporation, Johnson & Johnson, McKesson Medical-Surgical Inc., Hollister Incorporated, Lohmann & Rauscher International GmbH & Co. KG, Paul Hartmann AG, Kinetic Concepts Inc., Organogenesis Inc., Systagenix Wound Management Ltd.

North America was the largest region in the moist wound dressings market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the moist wound dressings market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the moist wound dressings market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs on imported wound care materials, polymers, and antimicrobial components have increased production and procurement costs, particularly affecting foam and hydrocolloid segments in regions dependent on global raw material supply. Asia-Pacific and European markets face delays and pricing fluctuations due to reliance on overseas manufacturing. At the same time, tariffs are pushing companies toward localized production, driving innovation in biodegradable and cost-efficient wound dressing materials.

The moist wound dressings market research report is one of a series of new reports that provides moist wound dressings market statistics, including moist wound dressings industry global market size, regional shares, competitors with a moist wound dressings market share, detailed moist wound dressings market segments, market trends and opportunities, and any further data you may need to thrive in the moist wound dressings industry. This moist wound dressings market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Moist wound dressing refers to products designed to protect wounds and prevent microbial infections while promoting faster healing. By maintaining a moist environment, these dressings support optimal re-epithelialization, act as a temporary physical barrier, and absorb wound exudate.

The main types of products in the moist wound dressing market include foam, alginate, hydrocolloid, hydrogel, and others. Foam dressings are used for partial- and full-thickness wounds with light, moderate, or heavy drainage and can serve as primary or secondary dressings. These dressings are applied in burns, pressure ulcers, diabetic ulcers, surgical wounds, and other wound types, with end users including hospitals, homecare providers, and others.

The moist wound dressings market consists of sales of films, NPWT dressings, gauze, composites, interactive dressings, antimicrobial dressings, collagens, elastic bandages, and sheets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.